Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients

To identify mutations associated with the virological response (VR) to a tipranavir-ritonavir (TPV/r)-based regimen, 143 patients previously treated with protease inhibitor (PI) were studied. VR was defined by a decrease of at least 1 log(10) in, or undetectable, human immunodeficiency virus (HIV) R...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Marcelin, Anne-Genevieve, Masquelier, Bernard, Descamps, Diane, Izopet, Jacques, Charpentier, Charlotte, Alloui, Chakib, Bouvier-Alias, Magali, Signori-Schmuck, Anne, Montes, Brigitte, Chaix, Marie-Laure, Amiel, Corinne, Santos, Georges Dos, Ruffault, Annick, Barin, Francis, Peytavin, Gilles, Lavignon, Marc, Flandre, Philippe, Calvez, Vincent
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society for Microbiology (ASM) 2008
विषय:
Antiviral Agents
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533483/
https://ncbi.nlm.nih.gov/pubmed/18625773
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00133-08
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन